Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

8:30 AM - 8:35 AM PT

1041 - Short-Term Clinical Outcomes of Conventional Versus Hypo-Fractionated Pelvic Radiotherapy for Locally Advanced Cervical Cancer
Speaker: Kavuma, Awusi, PhD - Uganda Cancer Institute, Kampala, Uganda
8:30 AM - 8:35 AM PT

1047 - Proposal for Future Refinement of N Category in Version-Nine of AJCC/UICC TNM Staging System for Nasopharyngeal Carcinoma based on the International Consensus Recommendations for Diagnosing Extranodal
Speaker: Zhong, Jing - Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian
8:30 AM - 8:35 AM PT

1053 - Optimizing Blood-Based Genomic Characterization of Oligometastatic Non-Small Cell Lung Cancer Patients
Speaker: Choi, Ariel, MD - Wake Forest Baptist Medical Center, Winston Salem, NC
8:30 AM - 8:40 AM PT

282 - Early-Stage Breast Cancer with Low Genomic Risk: Optimizing Adjuvant Therapy
Speaker: Miller, David, MD, MS - Memorial Sloan Kettering Cancer Center, New York, NY
8:30 AM - 8:40 AM PT

287 - Predictive Factors for Survival after Reirradiation of IDH Wild Type High Grade Glioma
Speaker: Petersen, John, DO - Wake Forest Baptist Medical Center, Winston Salem, NC
8:30 AM - 8:40 AM PT

292 - Maximal Ablative Irradiation Because of Encasement for Patients with Potentially Resectable Locally Advanced Pancreatic Cancer: Final Results of Phase II MAIBE Trial
Speaker: Reyngold, Marsha, MD, PhD - 303 E.60th St, New York, NY
8:30 AM - 8:40 AM PT

297 - Bridging the Gap between the Treatment Plan and In Vivo Dosimetry through Clinical Scintillation Imaging
Speaker: Clark, Megan, BS - Dartmouth College, Hanover, NH
8:40 AM - 8:50 AM PT

283 - Prognostic Significance of Lymph Node Tumor Deposit Size in Early-Stage Breast Cancer
Speaker: Roth OBrien, Diana, MD - Memorial Sloan Kettering Cancer Center, New York, NY
8:40 AM - 8:50 AM PT

288 - Comparing the Effectiveness of Hypofractionated Radiotherapy with Conventional Radiotherapy in High Grade Glioma Treatment: An Open Labelled Randomized Controlled Trial in a Tertiary Care Center in Ce
Speaker: Rajian, Simran, MBBS - All India Institute of Medical Sciences, Raipur, C.G, Raipur, Chhattisga
8:40 AM - 8:50 AM PT

293 - Patient-Specific TP53-Mutant Circulating Tumor DNA as a Prognostic Biomarker for Detection of Minimal Residual Disease after Neoadjuvant Concurrent Chemoradiotherapy followed by Esophagectomy in Local
Speaker: Cheng, Jason Chia-Hsien, MD, PhD, MS, FASTRO - National Taiwan University Hospital, Taipei, Taipei
8:40 AM - 8:50 AM PT

298 - 3D Surface Cherenkov Mapping for Quantitative Beam Deviation Assessment and Cumulative Cherenkov Image Fusion in Non-Coplanar RT
Speaker: Geiersbach, Alexander - Dartmouth College, Hanover, NH
8:50 AM - 9:00 AM PT

299 - Advancing Real-Time RT Monitoring with Cherenkov Imaging: Deep Learning-Based Segmentation of Patient Bio-Morphological Features
Speaker: Chen, Yao, BS - Dartmouth College, Hanover, NH